Clinical Trials Sponsored by Etnova Therapeutics Corp.

Total 21 results

Etnova Therapeutics Corp.

Recruiting

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Liver Cancer

Korea, Republic of
Aqualung Therapeutics Corp.

Not yet recruiting

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

Acute Respiratory Distress Syndrome (ARDS)
Pasithea Therapeutics Corp.

Recruiting

PAS-004 in Patients With Advanced Solid Tumors

Advanced Solid Tumors | RAS Mutation | NF1 Mutation | RAF Mutation

United States
Aqualung Therapeutics Corp.

Completed

First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100

ARDS, Human

Australia
Stem Cell Therapeutics Corp.

Withdrawn

REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)

Stroke

United States
Stem Cell Therapeutics Corp.

Terminated

Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS-LED)

Stroke

Canada, India, United States
Stem Cell Therapeutics Corp.

Terminated

REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)

Stroke

Canada, India
University of Alberta
Sernova Corp

Terminated

A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation

Type I Diabetes

Canada
Renova Therapeutics

Withdrawn

AC6 Gene Transfer in Patients With Reduced Left Ventricular Ejection Fraction Heart Failure (FLOURISH)

Heart Failure
University of Calgary
Stem Cell Therapeutics Corp.

Unknown

Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1

Traumatic Brain Injury

Canada
Nova Mentis Life Science Corp
FourthWall Testing

Recruiting

Establishing a Diagnostic and Therapeutic Index in Autism Spectrum Disorder (ASD) and Fragile X Syndrome

Autism Spectrum Disorder | Fra(X) Syndrome

United States
Nova Mentis Life Science Corp
KGK Science Inc.

Suspended

An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome

Cognitive Dysfunction | Fragile X Syndrome | Behavior

Canada
Sernova Corp
Juvenile Diabetes Research Foundation; University of Chicago; ICON plc

Recruiting

A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

Type 1 Diabetes Mellitus

United States
University of California, Irvine
Hoag Memorial Hospital Presbyterian; Stem Cell Therapeutics Corp.

Completed

Beta-hCG + Erythropoietin in Acute Stroke (BETAS)

Acute Stroke

United States
Nova Therapeutics LLC
Chinese PLA General Hospital

Recruiting

CART-PSMA Cells for Advanced Prostate Cancer

Prostate Cancer

China
Mononuclear Therapeutics Ltd.
Chinese University of Hong Kong; China Spinal Cord Injury Network

Unknown

Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia

Anemia, Neonatal | Hypoxic-Ischemic Encephalopathy | Hypoxia Neonatal | Cerebral Ischemia of Newborn

Hong Kong
Hammond, H. Kirk, M.D.
National Heart, Lung, and Blood Institute (NHLBI); Renova Therapeutics

Completed

AC6 Gene Transfer for CHF

Congestive Heart Failure

United States
Ruth M. Rothstein CORE Center
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects (DRIVESHAFT)

HIV

United States
ERP Biomarker Qualification Consortium
Merck Sharp & Dohme LLC; Novartis; Takeda; H. Lundbeck A/S; Astellas Pharma Inc; Alkermes... and other collaborators

Completed

Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers

Healthy

United States
ERP Biomarker Qualification Consortium
Merck Sharp & Dohme LLC; Novartis; Takeda; H. Lundbeck A/S; Columbia University; Astellas... and other collaborators

Completed

Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects

Schizophrenia

United States
US Department of Veterans Affairs
Bristol-Myers Squibb; Sanofi; GE Healthcare; Merck Sharp & Dohme LLC; Pfizer; Astra... and other collaborators

Completed

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

Myocardial Ischemia

United States, Canada

Clinical Trials Sponsored by Etnova Therapeutics Corp.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations